Powerful opioid claims first life in state

Carfentanil blamed for death of homeless man in Milwaukee

Carfentanil, a large-animal tranquilizer 10,000 times more potent than morphine, has been discovered in the system of a homeless man who died in Milwaukee last month, the Milwaukee County medical examiner’s office said Monday.

“We believe it is the first death in the entire state,” said the office’s operations manager, Karen Domagalski.

Carfentanil is an opioid in the same class as oxycodone, but it is 100 times more potent than fentanyl, which itself is 50 times more potent than heroin.

“It is crazy dangerous,” Chuck Rosenberg, the acting administrator of the federal Drug Enforcement Agency, said last year when issuing a special warning to emergency medical workers.

“We see it on the streets, often disguised as heroin,” he said. “I hope our first responders — and the public — will read and heed our health and safety warning.”

What constitutes a lethal dose of carfentanil for humans is unknown, DEA spokesman Ross Baer said.

A lethal dose of fentanyl is the size as a few grains of table salt, he said. “A lethal dose of carfentanil is not visible to the human eye.”

The development of a death tied to carfentanil comes as drug overdose deaths are soaring.

In Milwaukee County, a record 299 people died from drug overcarfentanil

doses in 2016, outstripping the 255 total deaths in 2015, which was itself a record. That number could grow while other suspected drug-related deaths await toxicology results.

Of the 299 confirmed drug-related deaths, about 45% — 132 — involved heroin. The number of deaths involving the potent painkiller fentanyl reached 80 — nearly tripling the number of cases from 2015.

Found dead in bedroom

According to a medical examiner’s report:

James W. Kinnee, 48, was found dead March 22 in a bedroom in the 5000 block of N. Teutonia Ave.

Kinnee, hired to do some roofing work in Milwaukee, and been living at the address with a female friend for only a few days.

A co-worker, noticing that Kinnee appeared to have no home, had allowed Kinnee and the woman to stay with him.

The co-worker, unable to wake Kinnee on March 22, went to work. When he returned, Kinnee was still in bed. When the co-worker called 911, the woman fled.

A family member told investigators that Kinnee was an alcoholic who had been in and out of various Milwaukee-area treatment shelters.

Investigators were attempting to confirm possible ties Kinnee may have to Florida, where carfentanil-related overdoses have been reported.

Carfentanil, manufactured in China, was first detected in Akron, Ohio, last summer, Baer said. In just three weeks, between July 5 and July 26, the city saw 236 overdoses. Fourteen people died.

The drug quickly spread to Pennsylvania, New Jersey, Georgia, Florida, Michigan, Indiana, Rhode Island, Illinois, West Virginia and Kentucky.

“When it hits an area, it hits with a vengeance,” Baer said.

In February, China’s National Narcotics Control Commission announced it would, beginning March 1, add carfentanil and three related synthetic opioids to its list of controlled substances.

“We’re hopeful that the export of carfentanil will be dramatically reduced,” Baer said.

That hope, Baer said, is tempered with the reality that, inevitably, some chemist somewhere will alter a molecule or two and find a way around these regulations.